SlideShare ist ein Scribd-Unternehmen logo
1 von 106
Downloaden Sie, um offline zu lesen
FUNDUS FLUORESCEIN ANGIOGRAPHY
SURAJ CHHETRI
B.Optometry
16th batch
Maharajgung medical campus , Nepal
PRESENTATION LAYOUT
• Introduction to fluorescein
• Basic principle of fluorescence
• Some terminologies
• Anatomical considerations
• Indication and contraindication of FFA
• Procedure of FFA
• Normal phases of FFA
• FFA interpretation
• FFA Vs ICG
• Phenomenon of FFA
INTRODUCTION OF FLUORESCEIN
• Orange water soluble dye
• When injected IV , it remains largely intravascular and circulates in
blood stream
• 70 – 85 % of fluorescein bind with blood serum albumin
• Rest of remain free i.e unbound form
• Sodium fluorescein : C20 H10 O5 Na2
CONTINUE…
• Properties
-Non-expensive
-Non-toxic
-Flouresces at blood PH level 7.37 – 7.45
-Rapid diffusion
• Synthesized from the petroleum derivatives resorcinol and phthalic anhydride
Chemically related to Phenolphthalein
• Molecular weight : 376 daltons
BASIC PRINCIPLE OF FLUORESCENCE
• Absorption followed by release of the radiant energy in the form of
visible light
• Fluorescent substance follows Stokes law
Stokes law
• Fluorescent substances absorbs light
• Molecular excitation
• Electrons elevated to higher less stable state  Returns to stable lower energy
form  Releasing light of longer wavelength  FLUORESCENCE
• Entire process – 10 – 8 sec.
BASIC PRINCIPLE OF FLUORESCENCE
• Absorption spectrum of fluorescein – 465 to 490 nm
• Excitation peak 490nm (blue part of spectrum )
• Emission spectrum of fluorescein – 520 to 530 nm
• Emission peak 530 nm (green-yellow spectrum )
NOTE
Absorbed radiant energy > emitted energy
AND
As energy – inversely proportional to –wavelength
SO,
λ of emitted wave > λ of absorbed wave
FILTERS FOR PROCEDURE
• Two type
• 1) blue barrier filter
• 2) yellow green barrier filter
• Blue barrier filter ensures that only the blue light enters the eye
• Yellow green barrier filter blocks the blue light reflects from the eye
• It allows green light to pass through unimpaired, to be recorded on the
film
TERMINOLOGIES
 Fluorescence- ability of a compound to absorb light of shorter
wavelength and emit light of longer wavelength with in a very short
interval
 Hyper-fluorescence – an area of abnormally high fluorescence due to
increase density of dye molecule
 Hypo-fluorescence - an area of abnormally poor fluorescence
 Auto-fluorescence – an inherent property of a lesion to spontaneously
fluoresce even in absence of dye
( observed before injection of the dye)
 Arm retina circulation time- from dye injection to first
appearance in retinal arteries( 10-12 sec)
Pooling- accumulation of dye in closed space .e.g. RPE
detachment, CSR
Leakage- dye escapes in open space e.g. vitreous space
Window defect- type of early hyper-fluorescence due to RPE
atrophy
Control photograph –photo taken before dye given to detect
auto-fluorescence
Staining- late hyperfluorescence due to adsorption of the dye by a
tissue
Blocked fluorescence – hypofluorescence occurs by masking
underlying retinal and choroidal tissue by blood , pigment etc.
Capillary nonperfusion – due to non filling of the retinal capillaries
due to anatomical and function reasons
Artifacts- undesirable shadows that are seen following the
development of the film
ANATOMICAL CONSIDERATION
• Major choroidal vessels are impermeable to both bound and unbound
form of fluorescein
BUT
Choriocapillaries
• Walls are extremely thin
• Contains multiple fenestrations
• Through which free molecules pass across Bruchs membrane
Choriocapillaries and Bruchs membrane both permeable to free and
bound fluorescein molecules
CONTINUE….
• Outer blood retinal barrier : tight junction between RPE cells prevent
passage of fluorescein
• Inner blood retinal barrier : tight junctins between endothelium cells of
retinal blood vessels prevent passage of fluorescein
• Fluorescein pass from choriocapillaries also passes through bruch’s
membrane but it encounter with tight junction intracellular complex zonula
occludens of RPE cells and prevent passage
• Disruption of barrier leak both bound and free fluorescein molecules
BLOOD VESSLES IN RETINA
• For FFA interpretation sensory retina divided into two layers
1. Inners vascular half ( ILM – INL )
 Here retinal blood vessels located in two separate planes
 large retinal arteries and veins located in nerve fiber layer
 Retinal capillaries located in inner nuclear layer
2. Outer avascular half (OPL – RPE )
• when retina becomes edematous ,
• it is the layer that fluid accumulate causing the cystoid space
PURPOSE OF FULUROSCEIN ANGIOGRAPHY
• Studying the normal physiology of the retinal and choroidal circulation,as
well as disease process affecting the macula.
• Evaluation of the vascular integrity of the retinal and choroidal vessels
• Check the integrity of the blood ocular barrier.
- Outer blood retinal barrier breaks in CSR
- Inner blood retinal barrier breaks in NVD, NVE
CONTINUE…
• It helps in clinical diagnosis
• To determine extent of damage
• To formulate treatment strategy for choroidal and retinal disease
• To monitor result of treatment
INDICATION OF FFA
Retinal vascular malformation and tumors
Retinal vascular disorders
Macular disorders
Choroidal disorders
Optic nerve disorders
Retinal diseases
1) Diabetic retinopathy
2) Retinal vein occlusions
3) Retinal artery occlusion
4) Retinal vasculitis
5) Coats disease
6) Familial exudative
vitreoretinopathy
Macular diseases
1) Central serous retinopathy
2) RPE detachment
3) Cystoid macular edema
4) Macular hole
5) ARMD
6) Cone rod dystrophy
7) Epiretinal membrane
8) Vitiliform dystrophies
9) Stargardts dystrophy
Retinal vascular malformations and tumors
1) Capillary hemangioma of retina
2) Cavernous hemangioma of retina
3) Retinal AV malformation
4) Congenital tortuosity of retinal vasculature
5) Congenital hypertrophy of RPE
6) Angioid streaks
7) Astrocytic hamartoma
Choroidal lesions
1) Choroidal neovascular (CNV)
2) Hemangioma
3) Nevus
4) Melanoma
5) Choroiditis
6) Choroidal folds
Optic nerve disorders
1) Optic atrophy
2) Papilloedema
3) Ischemic optic neuropathy
4) Optic disc pit
5) Optic disc drusen
6) Optic disc hemangioma
7) Melanocytoma
8) Myelinated nerve fibers
CONTRAINDICATIONS
ABSOLUTE
1) known allergy to iodine containing compounds.
2) H/O adverse reaction to FFA in the past.
RELATIVE
1) Asthma
2) Hay fever
3) Renal failure
4) Hepatic failure
5) Pregnancy ( especially 1st trimester)
MILD MODERATE SEVERE
Staining of skin,
sclera and mucous
membrane
Nausea and
vomiting
Respiratory-
laryngeal edema
,bhroncospasm
Stained secretion
Tear, saliva
Vasovagal response Circulatory shock,
MI, cardiac arrest
Vision tinged with
yellow
utricaria Generalized
convulsion
Orange-yellow urine fainting Skin necrosis
Skin flushing,
tingling lips pruritis
periphlebitis
COMPLICATIONS
COMPICATIONS MANAGEMENT
• Unavoidable minor side effects : treatment not needed
• Temporary tan skin colour, Red after image from the photoflash and
discoloration of the urine
• Transient Nausea and vomiting (10%): treatment not needed
• Vasovagal syncope (1%) :treatment not needed
• In extreme bradycardia
• IV atropine may be needed.
CONTINUE..
• Anaphylaxis such as bronchospasm, urticarial skin rash and
hypotension (<1%).
• Treatment is with chlorpheniramine (piriton) 10mg IV, hydrocortisone
100mg IV
• Hypotension and Bronchospasm
• oxygen and adrenaline 1ml of 1:1000 IM
• Cardiac and respiratory arrest (<0.01%)
• Treatment would involve cardiopulmonary resuscitation
EQUIPMENT AND MATERIALS NEEDED FOR ANGIOGRAPHY
Fundus camera and auxilliary equipment
Matched fluorescein filters ( barrier and exciter )
Digital photoprocessing unit ( computer based )
23 gauge scalp vein needle
5 ml syringe
5 ml of 10% OR 3ml of 25 % fluorescein solution
20 gauge , 1.5 inch needle to draw the dye
Armrest for fluorescein injection
Tourniquet
Alcohol swabs
Bandage
Standard emergency equipment
PROCEDURE
Patient is informed of the normal procedures, the side effects and the adverse
reactions.
Dilating the pupil
Made to sit comfortable.
3-4 red free photographs taken.
(control photographs)
5ml of 10% or 3ml of 25% NAF injected through the anticubital vein
Wait for 8 seconds for young and 12 seconds for older patients
( normal arm-retina time)
Photos are taken at 1 second interval for 10 seconds
Then every 2 seconds interval for 30 seconds
Late photographs are usually taken after 3 ,5 and 10 minutes.
CIRCULATION OF DYE
Dye injected from peripheral vein
venous circulation
heart
arterial system
INTERNAL CAROTID ARTERY
Ophthalmic artery
Short posterior ciliary artery) Central retinal
(choroidal circulation.) ( retinal circulation)
NORMAL PHASES IN FFA
•Early phase
• Choroidal(prearterial)
• Arterial
• Arteriovenous (capillary)
• Venous
• Early
• mid
• Late
•Mid phase
•Late phase
CONTINUE…
• Normally 10 -15 secs elapse between dye injection and arrival of dye
in the short ciliary arteries
• Choridal circulation preceeds retinal circulation by 1 Sec
• Transit- if dye through the retinal circulation takes approximately 15-
20 secs
EARLY PHASE
• Choroidal filling through the short ciliary arteries
• Initial patchy filling of lobules followed by diffused blush
as dye leaks out of choriocapillaries
• Cilioretinal vessels and prelaminar vessels and
prelaminar optic disc capilaries fill
Choroidal ( prearterial ) phase
FACTS OF PATCHY CHOROIDAL FILLING
• Choriocapillaries has number of lobules
• The lobules fill independently from one another,
• giving a transiently patched or blotched appearance
ARTERIAL PHASE
• Begins with the first appearance of fluorescein in the arteries, and
extends until the arteries are completely filled
• Posterior pole fills with dye earlier than the periphery
• Superior branches usually fill first
Arterial phase
ARTERIO-VENOUS PHASE(CAPILLARY PHASE)
• Complete filling of retinal arteries and capillaries.
• Early laminar flow in the veins in which dye is seen along the
lateral wall of the vein
• Choroidal fluorescence increases as free fluorescein continues to
leak from the choriocapillaries
Arteriovenous phase
VENOUS PHASE
• Gradually whole diameter of the veins is filled
• Earliest seen in the peripapillary and macular region
• Divided according to the venous filling and arterial emptying
• Early
• mid
• Late
EARLY VENOUS PHASE
• Arteries and capillaries are completely filled and marked lamellar
venous flow
MID VENOUS PHASE
• Some veins are completely filled
• Some shows marked laminar flow
LATE VENOUS PHASE
• All veins are completely filled and the arteries beginning to empty
MID PHASE
• Known as recirculation phase
• 2-4 min after injection
• Veins and arteries remain roughly equal in brightness.
• Intensity of fluorescein diminishes slowly as
• flourescein is removed from the blood stream on the first pass through
the kidneys.
LATE PHASE
• After 10-15 minutes little dye remains in the blood stream
• This phase demonstrates
• Gradual elimination of the dye from the retinal and choroidal
vasculature
• staining of optic disc , sclera is normal finding
• Any other hyperfluoresecence suggest the presence of abnormality
Late Phase
Phases of angiogram Time ( in seconds)
Injection 0
Posterior ciliary artery 9.5
Choroidal phase 10
Arterial 10 - 12
Arterio venous 13
Early venous 14 - 15
Mid venous 16 -17
Late venous 18 – 20
Late ( elimination) 5 minutes
FLUORESCENCE IN FOVEAL REGION
• Dark appearance WHY?
i) Avascularity in the FAZ
ii) Blockage of the choroidal
flourescein because of
• increased amount of xanthophyll
pigments at fovea
• melanin in RPE
NORMAL ANGIOGRAM
• Patchy filling of choroid
• Retinal blood vessels filling
• Dark area of foveal avascular zone
• But there is no hyper or hypofluroscence area
• At the end of the transit phase, fluorescein dye remains in the choroid
and sclera due to leakage from the choroidal vessels
• A small amount of fluorescein also remains in the optic nerve head and
retinal vessels, but there is no leakage
• Any additional fluorescein in the eye should be regarded as pathologic
NORMAL ANGIOGRAM
STEPWISE APPROCH TO FFA
• A fluorescein angiogram should be interpreted systematically to
optimize diagnostic accuracy as follows:-
• A ) Indicate whether images of right , left or both eyes have been
taken.
• B)comment on the red free images
• C)indicate any delay in filling as well as hyper or hypo
fluorescence
• D)indicate any characteristic features such as a smoke –stack or
lacy filling pattern.
54
FFA INTERPRETATION FLOW CHART
Fluorescein angiogram
Normal Abnormal Auto/pseudofluorescence
Hyperfluorescence Hypofluorescence
Leakage Pooling Staining Window Blocked Non
defect filling
NOTE
• Hyperfluorescence and hypofluorescence can alternate in same
location
• Especially in inflammatory disorder
• 1st hypofluorescence due to retinal oedema
• Later hyperfluorescence due to increased vascular permeability
AUTOFLUORESENCE
• Emission of fluorescence light in the absent of fluorescein
Example : optic nerve head drusen , astrocytic hematoma ,
myelinated nerve fibers
Optic disc drusen Astrocytic hematoma
PSEUDOFLUORESCENCE
• Occurs when nonfluorescence light passes through the entire filter system
• Blue reflected light passes from green filter pseudofluorescence occurs
• It decrease contrast aswell as resolution of image
• To avoid pseudofluorescence filter combination to be sure that no significant
overlap exists
• Over the time filter alter the range of light transmission so should be change
in certain time . Auther recommend about 5 year time to change filter
WINDOW DEFECT
• Focal RPE atrophy
• Unmasking of normal background of choroidal fluorescence
• Characterized by early hyperfluorescence which increases in intensity
then fade without changing shape and size
e.g. inflammation of RPE
atrophy of RPE , drusen
EXTRAVASCULAR LEAK
• Pooling and staining in choroid
• Cystoid edema and noncystoid edema in retina
• Neovascularization , inflammation and tumor vessels in vitreous
• Disc staining
Cystoid oedema of macula
Pooling( accumulation of dye
in a closed space)
-Early hyperfluorescence
sub-retinal space Early hyperfluorescence
sub RPE space
increase in size ,intensity increase intensity only
e.g. CSR e.g. PED
POOLING OF DYE
CSR( sub RETINAL space)PED( sub RPE space)
CSR increase in size and intensity
NVD
NVE
STAINING
• Accumulation of fluorescence within a tissue
• Due to prolonged dye retention
• Minimum hyperfluorescence in early and midphase which increases
in late phase
• Can be seen in normal as well as pathologically altered tissue
examples
RETINAL
a. non-cystoid macular oedema
b. Perivascular staining
SUB RETINAL
 Drusens
 Sclera
 Lamina cribrosa
 scars
Drusens in ARMD
LATE HYPERFLUROSCENCE ALONG THE EDGE OF GEORAPHIC SCAR
FOCAL EXUDATIVE
• Circumscribed retinal thickening
• Associated complete or incomplete
circinate hard exudates
• Focal leakage on FA
Optic Disc Swelling
HYPOFLURESCENCE
• Reduction or absence of fluorescein
• Two causes
BLOCKED
FLUORESCENCE
VASCULAR
FILLING
DEFECTS
BLOCKED FLUORESCENCE
• Optical obstruction (masking) of normal density of fluorescein
• Caused by lesions anterior to retina
• Pre-retinal lesions eg.vitreous opacity,preretinal
haemorrhage block all fluorescence
• Deep retinal lesions eg.intraretinal haemorrhage and
hard exudates block only capillary fluorescence
• Increased density of RPE eg.congenital hypertrophy
• Choroidal lesions eg.naevus
EXAMPLE
FILING DEFECTS
• Inadequate perfusion of tissue with resultant low fluorescein content
• Avascular occlusion of choroidal circulation or retinal
arteries,veins and capillaries
• Loss of vascular bed eg.severe myopic degeneration –
choroideremia
• Emboli
• arteriosclerosis
EXAMPLE
CRAO
CRVO
LIMITATIONS OF FFA
1) Does not permit study of choroidal circulation details
due to
a) melanin in RPE
b) low mol. Wt. of fluorescein
how to overcome ---- ICG
2) More adverse reaction
3) Inability to obtain angiogram in patient with excess
hemoglobin or serum protein
INDOCAINE GREEN ANGIOGRAPHY
• FFA excellent method for demonstrating retinal
circulation.
• But…
• Not helpful in delineating choroidal circulation
• ICG –of particular value in studying choroidal
circulation ,
• Can be useful adjunct to FA in investigation of macular
diseases.
FFA Vs ICG
PARAMETERS FFA ICG
1) Dye used Sodium fluorescein Indocyanine
green
2) Light used visible spectrum infrared
3) purpose study retinal
vasculature
Choroidal
vasculature
4) Filter used Blue- green Infra-red
5) expense lower higher
PHENOMENON OF FFA
• All the process of occurrence of hyper or hypo-fluorescence can be
described under following 3 phenomenons
A. OPTICAL PHENOMENON
B .MECHANICAL PHENOMENON
C. DYNAMIC PHENOMENON
OPTICAL PHENOMENON
• Normal neurosensory retina is transparent
• Normal RPE and Bruch’s Membrane are semitransparent
• Hence, we can see choroidal fluorescence
• BUT, this transparency can be pathologically increased or decreased
DECRESEING TRANSPARENCY
• In case of blocked fluorescence ,
transparency is lost
• SO, WE DO NOT SEE CHOROIDAL FLUORESCENCE
Accumulation of blood haemorrhage
RPE hypertrophy
Choroidal naevus
INCRESING TRANSPARENCY
• In case of staining due to drusens,angioid streaks ,scars and
degenerative processes
Accumulation of drusens under RPE
MECHANICAL PHENOMENON
• Related to adhesion of RPE to Bruch’s Membrane
• RPE firmly attached to Bruch’s membrane by hemidesmosomes
Absence of hemidesmosomes
RPE splits away from Bruch’s membrane
Fluorescein stained fluid accumulate in between them
eg. PIGMENT EPITHELIAL DETACHMENT
DYNAMIC PHENOMENON
• Related to diffusion of fluorescein in ocular tissue
• Determined by inner and outer blood retinal barrier I.E DIFFUSION
BARRIER
RETINAL VESSELS
• Normal retinal vessels do not leak fluorescein - due to zonula
occludents in between endothelial cells
• These zonula occludents open up during inflammatory process
Zonula occludents open up
normal
Endothelial cell is lost
Pores in endothelial cells
PERIVASCULITIS
DIABETIC
MICROANEURYSM
PROLIFERATED RETINAL
VESSELS
RETINAL PIGMENT EPITHELIUM
• Normal RPE is tight
• zonula occludens seal portion of all the intercellular spaces of the
pigment epithelial monolayer.
Cental serous
chorioretinopathy
Haemorrhagic PED in
wet ARMD
REFERENCES
INTERNATE
•Thank you

Weitere ähnliche Inhalte

Was ist angesagt? (20)

Pachymetry
PachymetryPachymetry
Pachymetry
 
Slit Lamp Illumination Techniques
Slit Lamp Illumination TechniquesSlit Lamp Illumination Techniques
Slit Lamp Illumination Techniques
 
Jackson cross cylinder
Jackson cross cylinderJackson cross cylinder
Jackson cross cylinder
 
Vitreous substitutes
Vitreous substitutesVitreous substitutes
Vitreous substitutes
 
binocular single vision
binocular single visionbinocular single vision
binocular single vision
 
Fundus fluorescein angiography and B-scan by vijay
Fundus  fluorescein angiography  and B-scan by vijayFundus  fluorescein angiography  and B-scan by vijay
Fundus fluorescein angiography and B-scan by vijay
 
Contrast sensitivity
Contrast sensitivityContrast sensitivity
Contrast sensitivity
 
Optical prism decentration
Optical prism decentrationOptical prism decentration
Optical prism decentration
 
Oct in glaucoma
Oct in glaucomaOct in glaucoma
Oct in glaucoma
 
Optic nerve head evaluation
Optic nerve head evaluationOptic nerve head evaluation
Optic nerve head evaluation
 
ARC: abnormal retinal correspondence, eccentric fixation
ARC: abnormal retinal correspondence, eccentric fixationARC: abnormal retinal correspondence, eccentric fixation
ARC: abnormal retinal correspondence, eccentric fixation
 
Hfa
HfaHfa
Hfa
 
Retinoscopy
RetinoscopyRetinoscopy
Retinoscopy
 
The pupil and it’s abnormalities
The pupil and it’s abnormalitiesThe pupil and it’s abnormalities
The pupil and it’s abnormalities
 
Near point of convergence
Near point of convergenceNear point of convergence
Near point of convergence
 
Glass prescription in children
Glass prescription in childrenGlass prescription in children
Glass prescription in children
 
Vertex distance and power
Vertex distance and powerVertex distance and power
Vertex distance and power
 
Role of oct in glaucoma
Role of oct in glaucomaRole of oct in glaucoma
Role of oct in glaucoma
 
B SCAN
B SCAN B SCAN
B SCAN
 
Optical aberrations
Optical aberrationsOptical aberrations
Optical aberrations
 

Andere mochten auch

celebrating World optometry day in nepal
 celebrating World optometry day  in nepal celebrating World optometry day  in nepal
celebrating World optometry day in nepalSuraj Chhetri
 
FFA syria
FFA syriaFFA syria
FFA syriasubhi89
 
fundus flourescien angiography
fundus flourescien angiographyfundus flourescien angiography
fundus flourescien angiographyVASIUR RAHMAN
 
Fundus Fluoroscein Angiography
Fundus Fluoroscein AngiographyFundus Fluoroscein Angiography
Fundus Fluoroscein AngiographyRashmi Ranjan
 
NW2006 BasicFFA for beginners
NW2006 BasicFFA for beginnersNW2006 BasicFFA for beginners
NW2006 BasicFFA for beginnersNawat Watanachai
 
BASIC INFO ON FUDUS FLORESCENCE ANGIOGRAPHY
BASIC INFO ON FUDUS FLORESCENCE ANGIOGRAPHYBASIC INFO ON FUDUS FLORESCENCE ANGIOGRAPHY
BASIC INFO ON FUDUS FLORESCENCE ANGIOGRAPHYNalin Nayan
 
Fundus Fluorescein Angiography
   Fundus Fluorescein Angiography   Fundus Fluorescein Angiography
Fundus Fluorescein Angiographykopila kafle
 
FUNDUS FLUORESCEIN ANGIOGRAPHY
FUNDUS FLUORESCEIN ANGIOGRAPHYFUNDUS FLUORESCEIN ANGIOGRAPHY
FUNDUS FLUORESCEIN ANGIOGRAPHYNishita Afrin
 
Reading Ffa In Diabetics 11 April 2010 by Dr. Anand Sudhalkar Vadodara
Reading Ffa In Diabetics 11 April 2010 by Dr. Anand Sudhalkar VadodaraReading Ffa In Diabetics 11 April 2010 by Dr. Anand Sudhalkar Vadodara
Reading Ffa In Diabetics 11 April 2010 by Dr. Anand Sudhalkar Vadodaraguest2dd8a9
 
Lenskart Brand Book
Lenskart Brand Book Lenskart Brand Book
Lenskart Brand Book valyoo
 
Optical low vision aids
Optical low vision aids Optical low vision aids
Optical low vision aids Meri Vukicevic
 
Management of central field loss
Management of central field lossManagement of central field loss
Management of central field lossMeri Vukicevic
 
Prescribing low vision devices by SURAJ CHHETRI
Prescribing low vision devices by SURAJ CHHETRIPrescribing low vision devices by SURAJ CHHETRI
Prescribing low vision devices by SURAJ CHHETRISuraj Chhetri
 
VISUAL FIELD by suraj chhetri
 VISUAL FIELD by suraj chhetri VISUAL FIELD by suraj chhetri
VISUAL FIELD by suraj chhetriSuraj Chhetri
 
INDOCYANINE GREEN ANGIOGRAPHY
INDOCYANINE GREEN ANGIOGRAPHYINDOCYANINE GREEN ANGIOGRAPHY
INDOCYANINE GREEN ANGIOGRAPHYPooja Kandula
 

Andere mochten auch (20)

celebrating World optometry day in nepal
 celebrating World optometry day  in nepal celebrating World optometry day  in nepal
celebrating World optometry day in nepal
 
FFA syria
FFA syriaFFA syria
FFA syria
 
fundus flourescien angiography
fundus flourescien angiographyfundus flourescien angiography
fundus flourescien angiography
 
Fundus Fluoroscein Angiography
Fundus Fluoroscein AngiographyFundus Fluoroscein Angiography
Fundus Fluoroscein Angiography
 
Fundus fluorescein angiography
Fundus fluorescein angiographyFundus fluorescein angiography
Fundus fluorescein angiography
 
NW2006 BasicFFA for beginners
NW2006 BasicFFA for beginnersNW2006 BasicFFA for beginners
NW2006 BasicFFA for beginners
 
Fundus Fluorescein Angiography
Fundus  Fluorescein AngiographyFundus  Fluorescein Angiography
Fundus Fluorescein Angiography
 
BASIC INFO ON FUDUS FLORESCENCE ANGIOGRAPHY
BASIC INFO ON FUDUS FLORESCENCE ANGIOGRAPHYBASIC INFO ON FUDUS FLORESCENCE ANGIOGRAPHY
BASIC INFO ON FUDUS FLORESCENCE ANGIOGRAPHY
 
Fundus Fluorescein Angiography
   Fundus Fluorescein Angiography   Fundus Fluorescein Angiography
Fundus Fluorescein Angiography
 
FUNDUS FLUORESCEIN ANGIOGRAPHY
FUNDUS FLUORESCEIN ANGIOGRAPHYFUNDUS FLUORESCEIN ANGIOGRAPHY
FUNDUS FLUORESCEIN ANGIOGRAPHY
 
Reading Ffa In Diabetics 11 April 2010 by Dr. Anand Sudhalkar Vadodara
Reading Ffa In Diabetics 11 April 2010 by Dr. Anand Sudhalkar VadodaraReading Ffa In Diabetics 11 April 2010 by Dr. Anand Sudhalkar Vadodara
Reading Ffa In Diabetics 11 April 2010 by Dr. Anand Sudhalkar Vadodara
 
Ffa history
Ffa historyFfa history
Ffa history
 
Ffa aios
Ffa aiosFfa aios
Ffa aios
 
Lenskart Brand Book
Lenskart Brand Book Lenskart Brand Book
Lenskart Brand Book
 
Ocular angiography
Ocular angiographyOcular angiography
Ocular angiography
 
Optical low vision aids
Optical low vision aids Optical low vision aids
Optical low vision aids
 
Management of central field loss
Management of central field lossManagement of central field loss
Management of central field loss
 
Prescribing low vision devices by SURAJ CHHETRI
Prescribing low vision devices by SURAJ CHHETRIPrescribing low vision devices by SURAJ CHHETRI
Prescribing low vision devices by SURAJ CHHETRI
 
VISUAL FIELD by suraj chhetri
 VISUAL FIELD by suraj chhetri VISUAL FIELD by suraj chhetri
VISUAL FIELD by suraj chhetri
 
INDOCYANINE GREEN ANGIOGRAPHY
INDOCYANINE GREEN ANGIOGRAPHYINDOCYANINE GREEN ANGIOGRAPHY
INDOCYANINE GREEN ANGIOGRAPHY
 

Ähnlich wie Ffa by suraj chhetri

Fundus fluroscein angiography
Fundus fluroscein angiographyFundus fluroscein angiography
Fundus fluroscein angiographyShruti Laddha
 
Ffa and icg
Ffa  and icgFfa  and icg
Ffa and icgnrvdad
 
fundus fluorescein and indocyanine green angiography
fundus fluorescein and indocyanine green angiographyfundus fluorescein and indocyanine green angiography
fundus fluorescein and indocyanine green angiographyHaitham Al Mahrouqi
 
98967f8c6ec465e03a7f80b29928ece1copy-230926184118-2578187b.pdf
98967f8c6ec465e03a7f80b29928ece1copy-230926184118-2578187b.pdf98967f8c6ec465e03a7f80b29928ece1copy-230926184118-2578187b.pdf
98967f8c6ec465e03a7f80b29928ece1copy-230926184118-2578187b.pdfMainaBidiyasar
 
Presentation.pptx
Presentation.pptxPresentation.pptx
Presentation.pptxDivya785180
 
Fundus fluorescein angiography of retina
Fundus fluorescein angiography of retinaFundus fluorescein angiography of retina
Fundus fluorescein angiography of retinaNikita Jaiswal
 
fundus fluorescein angiography V/S indocyanine green angiography
fundus fluorescein angiography V/S indocyanine green angiographyfundus fluorescein angiography V/S indocyanine green angiography
fundus fluorescein angiography V/S indocyanine green angiographyparesh nichlani
 
Fundus Flourescein Angiography( FFA ) by optometry fans.pptx
Fundus Flourescein Angiography( FFA ) by optometry fans.pptxFundus Flourescein Angiography( FFA ) by optometry fans.pptx
Fundus Flourescein Angiography( FFA ) by optometry fans.pptxoptometry fans
 
Fundus Fluorescence Angiography
Fundus Fluorescence Angiography Fundus Fluorescence Angiography
Fundus Fluorescence Angiography abhishek ghelani
 

Ähnlich wie Ffa by suraj chhetri (20)

ffa-180529050618.pdf
ffa-180529050618.pdfffa-180529050618.pdf
ffa-180529050618.pdf
 
ffa-180529050618.pdf
ffa-180529050618.pdfffa-180529050618.pdf
ffa-180529050618.pdf
 
Fundus fluroscein angiography
Fundus fluroscein angiographyFundus fluroscein angiography
Fundus fluroscein angiography
 
Ffa and icg
Ffa  and icgFfa  and icg
Ffa and icg
 
fundus fluorescein and indocyanine green angiography
fundus fluorescein and indocyanine green angiographyfundus fluorescein and indocyanine green angiography
fundus fluorescein and indocyanine green angiography
 
FFA and ICG
FFA and ICGFFA and ICG
FFA and ICG
 
98967f8c6ec465e03a7f80b29928ece1copy-230926184118-2578187b.pdf
98967f8c6ec465e03a7f80b29928ece1copy-230926184118-2578187b.pdf98967f8c6ec465e03a7f80b29928ece1copy-230926184118-2578187b.pdf
98967f8c6ec465e03a7f80b29928ece1copy-230926184118-2578187b.pdf
 
FFA AND ICG
FFA AND ICGFFA AND ICG
FFA AND ICG
 
Fundus fl. angio
Fundus fl. angioFundus fl. angio
Fundus fl. angio
 
FFA Dr Md Afzal Mahfuzullah
FFA Dr Md Afzal MahfuzullahFFA Dr Md Afzal Mahfuzullah
FFA Dr Md Afzal Mahfuzullah
 
Fluorescein Angiography
Fluorescein AngiographyFluorescein Angiography
Fluorescein Angiography
 
FFA ppt.pptx
FFA ppt.pptxFFA ppt.pptx
FFA ppt.pptx
 
Presentation.pptx
Presentation.pptxPresentation.pptx
Presentation.pptx
 
Fundus fluorescein angiography of retina
Fundus fluorescein angiography of retinaFundus fluorescein angiography of retina
Fundus fluorescein angiography of retina
 
fundus fluorescein angiography V/S indocyanine green angiography
fundus fluorescein angiography V/S indocyanine green angiographyfundus fluorescein angiography V/S indocyanine green angiography
fundus fluorescein angiography V/S indocyanine green angiography
 
Fundus Flourescein Angiography( FFA ) by optometry fans.pptx
Fundus Flourescein Angiography( FFA ) by optometry fans.pptxFundus Flourescein Angiography( FFA ) by optometry fans.pptx
Fundus Flourescein Angiography( FFA ) by optometry fans.pptx
 
Eye Flourecein Angiography
Eye Flourecein AngiographyEye Flourecein Angiography
Eye Flourecein Angiography
 
Fundus Fluorescence Angiography
Fundus Fluorescence Angiography Fundus Fluorescence Angiography
Fundus Fluorescence Angiography
 
Retinopathy of prematurity
Retinopathy of prematurityRetinopathy of prematurity
Retinopathy of prematurity
 
MACULAR DYSTROPHY
MACULAR DYSTROPHYMACULAR DYSTROPHY
MACULAR DYSTROPHY
 

Mehr von Suraj Chhetri

Abberation by suraj chhetri
Abberation by suraj chhetriAbberation by suraj chhetri
Abberation by suraj chhetriSuraj Chhetri
 
Inflammation by suraj chhetri
Inflammation by suraj chhetriInflammation by suraj chhetri
Inflammation by suraj chhetriSuraj Chhetri
 
Journal club about computer vision syndrome suraj chhetri
Journal club about computer vision syndrome  suraj chhetriJournal club about computer vision syndrome  suraj chhetri
Journal club about computer vision syndrome suraj chhetriSuraj Chhetri
 
Corneal topography by suraj
Corneal topography by surajCorneal topography by suraj
Corneal topography by surajSuraj Chhetri
 
Aphakia by SURAJ CHHETRI
Aphakia  by SURAJ CHHETRIAphakia  by SURAJ CHHETRI
Aphakia by SURAJ CHHETRISuraj Chhetri
 
Suraj ..lacrimal appartus ppt (2)
Suraj ..lacrimal appartus ppt (2)Suraj ..lacrimal appartus ppt (2)
Suraj ..lacrimal appartus ppt (2)Suraj Chhetri
 
Suraj chhetri retina
Suraj chhetri retinaSuraj chhetri retina
Suraj chhetri retinaSuraj Chhetri
 

Mehr von Suraj Chhetri (9)

Abberation by suraj chhetri
Abberation by suraj chhetriAbberation by suraj chhetri
Abberation by suraj chhetri
 
Inflammation by suraj chhetri
Inflammation by suraj chhetriInflammation by suraj chhetri
Inflammation by suraj chhetri
 
Journal club about computer vision syndrome suraj chhetri
Journal club about computer vision syndrome  suraj chhetriJournal club about computer vision syndrome  suraj chhetri
Journal club about computer vision syndrome suraj chhetri
 
Corneal topography by suraj
Corneal topography by surajCorneal topography by suraj
Corneal topography by suraj
 
Aphakia by SURAJ CHHETRI
Aphakia  by SURAJ CHHETRIAphakia  by SURAJ CHHETRI
Aphakia by SURAJ CHHETRI
 
Steroid suraj
Steroid surajSteroid suraj
Steroid suraj
 
Suraj ..lacrimal appartus ppt (2)
Suraj ..lacrimal appartus ppt (2)Suraj ..lacrimal appartus ppt (2)
Suraj ..lacrimal appartus ppt (2)
 
Suraj chhetri retina
Suraj chhetri retinaSuraj chhetri retina
Suraj chhetri retina
 
Laser surazz
Laser   surazzLaser   surazz
Laser surazz
 

Kürzlich hochgeladen

Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptxL1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptxDr Bilal Natiq
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
LESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingLESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingSakthi Kathiravan
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseSreenivasa Reddy Thalla
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMADivya Kanojiya
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxEyobAlemu11
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxEx WHO/USAID
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 

Kürzlich hochgeladen (20)

Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptxL1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
LESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingLESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursing
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies Disease
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptx
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptx
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 

Ffa by suraj chhetri

  • 1. FUNDUS FLUORESCEIN ANGIOGRAPHY SURAJ CHHETRI B.Optometry 16th batch Maharajgung medical campus , Nepal
  • 2. PRESENTATION LAYOUT • Introduction to fluorescein • Basic principle of fluorescence • Some terminologies • Anatomical considerations • Indication and contraindication of FFA • Procedure of FFA • Normal phases of FFA • FFA interpretation • FFA Vs ICG • Phenomenon of FFA
  • 3. INTRODUCTION OF FLUORESCEIN • Orange water soluble dye • When injected IV , it remains largely intravascular and circulates in blood stream • 70 – 85 % of fluorescein bind with blood serum albumin • Rest of remain free i.e unbound form • Sodium fluorescein : C20 H10 O5 Na2
  • 4. CONTINUE… • Properties -Non-expensive -Non-toxic -Flouresces at blood PH level 7.37 – 7.45 -Rapid diffusion • Synthesized from the petroleum derivatives resorcinol and phthalic anhydride Chemically related to Phenolphthalein • Molecular weight : 376 daltons
  • 5. BASIC PRINCIPLE OF FLUORESCENCE • Absorption followed by release of the radiant energy in the form of visible light • Fluorescent substance follows Stokes law Stokes law • Fluorescent substances absorbs light • Molecular excitation • Electrons elevated to higher less stable state  Returns to stable lower energy form  Releasing light of longer wavelength  FLUORESCENCE • Entire process – 10 – 8 sec.
  • 6. BASIC PRINCIPLE OF FLUORESCENCE • Absorption spectrum of fluorescein – 465 to 490 nm • Excitation peak 490nm (blue part of spectrum ) • Emission spectrum of fluorescein – 520 to 530 nm • Emission peak 530 nm (green-yellow spectrum )
  • 7. NOTE Absorbed radiant energy > emitted energy AND As energy – inversely proportional to –wavelength SO, λ of emitted wave > λ of absorbed wave
  • 8. FILTERS FOR PROCEDURE • Two type • 1) blue barrier filter • 2) yellow green barrier filter • Blue barrier filter ensures that only the blue light enters the eye
  • 9. • Yellow green barrier filter blocks the blue light reflects from the eye • It allows green light to pass through unimpaired, to be recorded on the film
  • 10. TERMINOLOGIES  Fluorescence- ability of a compound to absorb light of shorter wavelength and emit light of longer wavelength with in a very short interval  Hyper-fluorescence – an area of abnormally high fluorescence due to increase density of dye molecule  Hypo-fluorescence - an area of abnormally poor fluorescence  Auto-fluorescence – an inherent property of a lesion to spontaneously fluoresce even in absence of dye ( observed before injection of the dye)
  • 11.  Arm retina circulation time- from dye injection to first appearance in retinal arteries( 10-12 sec) Pooling- accumulation of dye in closed space .e.g. RPE detachment, CSR Leakage- dye escapes in open space e.g. vitreous space Window defect- type of early hyper-fluorescence due to RPE atrophy Control photograph –photo taken before dye given to detect auto-fluorescence
  • 12. Staining- late hyperfluorescence due to adsorption of the dye by a tissue Blocked fluorescence – hypofluorescence occurs by masking underlying retinal and choroidal tissue by blood , pigment etc. Capillary nonperfusion – due to non filling of the retinal capillaries due to anatomical and function reasons Artifacts- undesirable shadows that are seen following the development of the film
  • 13. ANATOMICAL CONSIDERATION • Major choroidal vessels are impermeable to both bound and unbound form of fluorescein BUT Choriocapillaries • Walls are extremely thin • Contains multiple fenestrations • Through which free molecules pass across Bruchs membrane Choriocapillaries and Bruchs membrane both permeable to free and bound fluorescein molecules
  • 14. CONTINUE…. • Outer blood retinal barrier : tight junction between RPE cells prevent passage of fluorescein • Inner blood retinal barrier : tight junctins between endothelium cells of retinal blood vessels prevent passage of fluorescein • Fluorescein pass from choriocapillaries also passes through bruch’s membrane but it encounter with tight junction intracellular complex zonula occludens of RPE cells and prevent passage • Disruption of barrier leak both bound and free fluorescein molecules
  • 15.
  • 16. BLOOD VESSLES IN RETINA • For FFA interpretation sensory retina divided into two layers 1. Inners vascular half ( ILM – INL )  Here retinal blood vessels located in two separate planes  large retinal arteries and veins located in nerve fiber layer  Retinal capillaries located in inner nuclear layer 2. Outer avascular half (OPL – RPE ) • when retina becomes edematous , • it is the layer that fluid accumulate causing the cystoid space
  • 17.
  • 18. PURPOSE OF FULUROSCEIN ANGIOGRAPHY • Studying the normal physiology of the retinal and choroidal circulation,as well as disease process affecting the macula. • Evaluation of the vascular integrity of the retinal and choroidal vessels • Check the integrity of the blood ocular barrier. - Outer blood retinal barrier breaks in CSR - Inner blood retinal barrier breaks in NVD, NVE
  • 19. CONTINUE… • It helps in clinical diagnosis • To determine extent of damage • To formulate treatment strategy for choroidal and retinal disease • To monitor result of treatment
  • 20. INDICATION OF FFA Retinal vascular malformation and tumors Retinal vascular disorders Macular disorders Choroidal disorders Optic nerve disorders
  • 21. Retinal diseases 1) Diabetic retinopathy 2) Retinal vein occlusions 3) Retinal artery occlusion 4) Retinal vasculitis 5) Coats disease 6) Familial exudative vitreoretinopathy Macular diseases 1) Central serous retinopathy 2) RPE detachment 3) Cystoid macular edema 4) Macular hole 5) ARMD 6) Cone rod dystrophy 7) Epiretinal membrane 8) Vitiliform dystrophies 9) Stargardts dystrophy
  • 22. Retinal vascular malformations and tumors 1) Capillary hemangioma of retina 2) Cavernous hemangioma of retina 3) Retinal AV malformation 4) Congenital tortuosity of retinal vasculature 5) Congenital hypertrophy of RPE 6) Angioid streaks 7) Astrocytic hamartoma
  • 23. Choroidal lesions 1) Choroidal neovascular (CNV) 2) Hemangioma 3) Nevus 4) Melanoma 5) Choroiditis 6) Choroidal folds Optic nerve disorders 1) Optic atrophy 2) Papilloedema 3) Ischemic optic neuropathy 4) Optic disc pit 5) Optic disc drusen 6) Optic disc hemangioma 7) Melanocytoma 8) Myelinated nerve fibers
  • 24. CONTRAINDICATIONS ABSOLUTE 1) known allergy to iodine containing compounds. 2) H/O adverse reaction to FFA in the past. RELATIVE 1) Asthma 2) Hay fever 3) Renal failure 4) Hepatic failure 5) Pregnancy ( especially 1st trimester)
  • 25. MILD MODERATE SEVERE Staining of skin, sclera and mucous membrane Nausea and vomiting Respiratory- laryngeal edema ,bhroncospasm Stained secretion Tear, saliva Vasovagal response Circulatory shock, MI, cardiac arrest Vision tinged with yellow utricaria Generalized convulsion Orange-yellow urine fainting Skin necrosis Skin flushing, tingling lips pruritis periphlebitis COMPLICATIONS
  • 26. COMPICATIONS MANAGEMENT • Unavoidable minor side effects : treatment not needed • Temporary tan skin colour, Red after image from the photoflash and discoloration of the urine • Transient Nausea and vomiting (10%): treatment not needed • Vasovagal syncope (1%) :treatment not needed • In extreme bradycardia • IV atropine may be needed.
  • 27. CONTINUE.. • Anaphylaxis such as bronchospasm, urticarial skin rash and hypotension (<1%). • Treatment is with chlorpheniramine (piriton) 10mg IV, hydrocortisone 100mg IV • Hypotension and Bronchospasm • oxygen and adrenaline 1ml of 1:1000 IM • Cardiac and respiratory arrest (<0.01%) • Treatment would involve cardiopulmonary resuscitation
  • 28. EQUIPMENT AND MATERIALS NEEDED FOR ANGIOGRAPHY Fundus camera and auxilliary equipment Matched fluorescein filters ( barrier and exciter ) Digital photoprocessing unit ( computer based ) 23 gauge scalp vein needle 5 ml syringe 5 ml of 10% OR 3ml of 25 % fluorescein solution
  • 29. 20 gauge , 1.5 inch needle to draw the dye Armrest for fluorescein injection Tourniquet Alcohol swabs Bandage Standard emergency equipment
  • 30. PROCEDURE Patient is informed of the normal procedures, the side effects and the adverse reactions. Dilating the pupil Made to sit comfortable. 3-4 red free photographs taken. (control photographs) 5ml of 10% or 3ml of 25% NAF injected through the anticubital vein
  • 31. Wait for 8 seconds for young and 12 seconds for older patients ( normal arm-retina time) Photos are taken at 1 second interval for 10 seconds Then every 2 seconds interval for 30 seconds Late photographs are usually taken after 3 ,5 and 10 minutes.
  • 32. CIRCULATION OF DYE Dye injected from peripheral vein venous circulation heart arterial system INTERNAL CAROTID ARTERY Ophthalmic artery Short posterior ciliary artery) Central retinal (choroidal circulation.) ( retinal circulation)
  • 33. NORMAL PHASES IN FFA •Early phase • Choroidal(prearterial) • Arterial • Arteriovenous (capillary) • Venous • Early • mid • Late •Mid phase •Late phase
  • 34.
  • 35. CONTINUE… • Normally 10 -15 secs elapse between dye injection and arrival of dye in the short ciliary arteries • Choridal circulation preceeds retinal circulation by 1 Sec • Transit- if dye through the retinal circulation takes approximately 15- 20 secs
  • 36. EARLY PHASE • Choroidal filling through the short ciliary arteries • Initial patchy filling of lobules followed by diffused blush as dye leaks out of choriocapillaries • Cilioretinal vessels and prelaminar vessels and prelaminar optic disc capilaries fill Choroidal ( prearterial ) phase
  • 37.
  • 38. FACTS OF PATCHY CHOROIDAL FILLING • Choriocapillaries has number of lobules • The lobules fill independently from one another, • giving a transiently patched or blotched appearance
  • 39. ARTERIAL PHASE • Begins with the first appearance of fluorescein in the arteries, and extends until the arteries are completely filled • Posterior pole fills with dye earlier than the periphery • Superior branches usually fill first
  • 41. ARTERIO-VENOUS PHASE(CAPILLARY PHASE) • Complete filling of retinal arteries and capillaries. • Early laminar flow in the veins in which dye is seen along the lateral wall of the vein • Choroidal fluorescence increases as free fluorescein continues to leak from the choriocapillaries
  • 43. VENOUS PHASE • Gradually whole diameter of the veins is filled • Earliest seen in the peripapillary and macular region • Divided according to the venous filling and arterial emptying • Early • mid • Late
  • 44. EARLY VENOUS PHASE • Arteries and capillaries are completely filled and marked lamellar venous flow
  • 45. MID VENOUS PHASE • Some veins are completely filled • Some shows marked laminar flow
  • 46. LATE VENOUS PHASE • All veins are completely filled and the arteries beginning to empty
  • 47. MID PHASE • Known as recirculation phase • 2-4 min after injection • Veins and arteries remain roughly equal in brightness. • Intensity of fluorescein diminishes slowly as • flourescein is removed from the blood stream on the first pass through the kidneys.
  • 48. LATE PHASE • After 10-15 minutes little dye remains in the blood stream • This phase demonstrates • Gradual elimination of the dye from the retinal and choroidal vasculature • staining of optic disc , sclera is normal finding • Any other hyperfluoresecence suggest the presence of abnormality
  • 50. Phases of angiogram Time ( in seconds) Injection 0 Posterior ciliary artery 9.5 Choroidal phase 10 Arterial 10 - 12 Arterio venous 13 Early venous 14 - 15 Mid venous 16 -17 Late venous 18 – 20 Late ( elimination) 5 minutes
  • 51. FLUORESCENCE IN FOVEAL REGION • Dark appearance WHY? i) Avascularity in the FAZ ii) Blockage of the choroidal flourescein because of • increased amount of xanthophyll pigments at fovea • melanin in RPE
  • 52. NORMAL ANGIOGRAM • Patchy filling of choroid • Retinal blood vessels filling • Dark area of foveal avascular zone • But there is no hyper or hypofluroscence area • At the end of the transit phase, fluorescein dye remains in the choroid and sclera due to leakage from the choroidal vessels • A small amount of fluorescein also remains in the optic nerve head and retinal vessels, but there is no leakage • Any additional fluorescein in the eye should be regarded as pathologic
  • 54. STEPWISE APPROCH TO FFA • A fluorescein angiogram should be interpreted systematically to optimize diagnostic accuracy as follows:- • A ) Indicate whether images of right , left or both eyes have been taken. • B)comment on the red free images • C)indicate any delay in filling as well as hyper or hypo fluorescence • D)indicate any characteristic features such as a smoke –stack or lacy filling pattern. 54
  • 55. FFA INTERPRETATION FLOW CHART Fluorescein angiogram Normal Abnormal Auto/pseudofluorescence Hyperfluorescence Hypofluorescence Leakage Pooling Staining Window Blocked Non defect filling
  • 56. NOTE • Hyperfluorescence and hypofluorescence can alternate in same location • Especially in inflammatory disorder • 1st hypofluorescence due to retinal oedema • Later hyperfluorescence due to increased vascular permeability
  • 57.
  • 58. AUTOFLUORESENCE • Emission of fluorescence light in the absent of fluorescein Example : optic nerve head drusen , astrocytic hematoma , myelinated nerve fibers Optic disc drusen Astrocytic hematoma
  • 59. PSEUDOFLUORESCENCE • Occurs when nonfluorescence light passes through the entire filter system • Blue reflected light passes from green filter pseudofluorescence occurs • It decrease contrast aswell as resolution of image • To avoid pseudofluorescence filter combination to be sure that no significant overlap exists • Over the time filter alter the range of light transmission so should be change in certain time . Auther recommend about 5 year time to change filter
  • 60. WINDOW DEFECT • Focal RPE atrophy • Unmasking of normal background of choroidal fluorescence • Characterized by early hyperfluorescence which increases in intensity then fade without changing shape and size e.g. inflammation of RPE atrophy of RPE , drusen
  • 61.
  • 62. EXTRAVASCULAR LEAK • Pooling and staining in choroid • Cystoid edema and noncystoid edema in retina • Neovascularization , inflammation and tumor vessels in vitreous • Disc staining Cystoid oedema of macula
  • 63. Pooling( accumulation of dye in a closed space) -Early hyperfluorescence sub-retinal space Early hyperfluorescence sub RPE space increase in size ,intensity increase intensity only e.g. CSR e.g. PED
  • 64. POOLING OF DYE CSR( sub RETINAL space)PED( sub RPE space)
  • 65. CSR increase in size and intensity
  • 67. STAINING • Accumulation of fluorescence within a tissue • Due to prolonged dye retention • Minimum hyperfluorescence in early and midphase which increases in late phase • Can be seen in normal as well as pathologically altered tissue
  • 68. examples RETINAL a. non-cystoid macular oedema b. Perivascular staining SUB RETINAL  Drusens  Sclera  Lamina cribrosa  scars
  • 70. LATE HYPERFLUROSCENCE ALONG THE EDGE OF GEORAPHIC SCAR
  • 71. FOCAL EXUDATIVE • Circumscribed retinal thickening • Associated complete or incomplete circinate hard exudates • Focal leakage on FA
  • 73. HYPOFLURESCENCE • Reduction or absence of fluorescein • Two causes BLOCKED FLUORESCENCE VASCULAR FILLING DEFECTS
  • 74. BLOCKED FLUORESCENCE • Optical obstruction (masking) of normal density of fluorescein • Caused by lesions anterior to retina • Pre-retinal lesions eg.vitreous opacity,preretinal haemorrhage block all fluorescence • Deep retinal lesions eg.intraretinal haemorrhage and hard exudates block only capillary fluorescence • Increased density of RPE eg.congenital hypertrophy • Choroidal lesions eg.naevus EXAMPLE
  • 75.
  • 76.
  • 77.
  • 78.
  • 79. FILING DEFECTS • Inadequate perfusion of tissue with resultant low fluorescein content • Avascular occlusion of choroidal circulation or retinal arteries,veins and capillaries • Loss of vascular bed eg.severe myopic degeneration – choroideremia • Emboli • arteriosclerosis EXAMPLE
  • 81. LIMITATIONS OF FFA 1) Does not permit study of choroidal circulation details due to a) melanin in RPE b) low mol. Wt. of fluorescein how to overcome ---- ICG 2) More adverse reaction 3) Inability to obtain angiogram in patient with excess hemoglobin or serum protein
  • 82. INDOCAINE GREEN ANGIOGRAPHY • FFA excellent method for demonstrating retinal circulation. • But… • Not helpful in delineating choroidal circulation • ICG –of particular value in studying choroidal circulation , • Can be useful adjunct to FA in investigation of macular diseases.
  • 83. FFA Vs ICG PARAMETERS FFA ICG 1) Dye used Sodium fluorescein Indocyanine green 2) Light used visible spectrum infrared 3) purpose study retinal vasculature Choroidal vasculature 4) Filter used Blue- green Infra-red 5) expense lower higher
  • 84. PHENOMENON OF FFA • All the process of occurrence of hyper or hypo-fluorescence can be described under following 3 phenomenons A. OPTICAL PHENOMENON B .MECHANICAL PHENOMENON C. DYNAMIC PHENOMENON
  • 85. OPTICAL PHENOMENON • Normal neurosensory retina is transparent • Normal RPE and Bruch’s Membrane are semitransparent • Hence, we can see choroidal fluorescence • BUT, this transparency can be pathologically increased or decreased
  • 86. DECRESEING TRANSPARENCY • In case of blocked fluorescence , transparency is lost • SO, WE DO NOT SEE CHOROIDAL FLUORESCENCE
  • 87. Accumulation of blood haemorrhage
  • 89. INCRESING TRANSPARENCY • In case of staining due to drusens,angioid streaks ,scars and degenerative processes
  • 91. MECHANICAL PHENOMENON • Related to adhesion of RPE to Bruch’s Membrane • RPE firmly attached to Bruch’s membrane by hemidesmosomes
  • 92.
  • 93. Absence of hemidesmosomes RPE splits away from Bruch’s membrane Fluorescein stained fluid accumulate in between them eg. PIGMENT EPITHELIAL DETACHMENT
  • 94.
  • 95. DYNAMIC PHENOMENON • Related to diffusion of fluorescein in ocular tissue • Determined by inner and outer blood retinal barrier I.E DIFFUSION BARRIER
  • 96. RETINAL VESSELS • Normal retinal vessels do not leak fluorescein - due to zonula occludents in between endothelial cells • These zonula occludents open up during inflammatory process
  • 97. Zonula occludents open up normal Endothelial cell is lost Pores in endothelial cells
  • 101. RETINAL PIGMENT EPITHELIUM • Normal RPE is tight • zonula occludens seal portion of all the intercellular spaces of the pigment epithelial monolayer.
  • 102.